StockClub

XTLB

XTLBXTL Biopharmaceuticals Ltd.$ --
XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

XTLB

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2024FY2024 Q4
Revenue
0M USD
YoY +Infinity%
Operating Income
-1M USD
YoY -306.0%
Net Income
-0M USD
YoY +10.2%
EPS
-0.16$
YoY +20.0%

Revenue

$451,000
FY2023 Q1$0
$0
Q1
FY2023 Q2$0
$0
Q2
FY2023 Q3$0
$0
Q3
FY2023 Q4$0
$0
Q4
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$162,000
$162,000
Q3
FY2024 Q4$451,000
$451,000
Q4
Actual
+$451,000 (-)

Net Income

$-1M
FY2023 Q1$-919,000
$-919,000
Q1
FY2023 Q2$-1.3M
$-1.3M
Q2
FY2023 Q3$-1.5M
$-1.5M
Q3
FY2023 Q4$-1.8M
$-1.8M
Q4
FY2024 Q1$485,000
$485,000
Q1
FY2024 Q2$-219,000
$-219,000
Q2
FY2024 Q3$-772,000
$-772,000
Q3
FY2024 Q4$-1M
$-1M
Q4
Actual
+$755,000 (+42.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$0
FY2019
$0
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024
Actual:$451,000
FY2024
$451,000

Analyst Estimates

No forecast data